HIGHLIGHTS
- who: _Page.qxd et al. from the est dernier antifongique à être approuvé au CanadaUniversity Health have published the paper: 11192_Page.qxd 25/07/2008 10:15 Posaconazole: A new for the prevention invasive fungal infections AV WC Posaconazole: A new for the fungal infections, in the Journal: (JOURNAL)
- what: Despite the diverse spectrum of activity indicated by in_vitro and in_vivo experimental data, posaconazole has received Canadian approval only for the treatment of OPC and refractory invasive aspergillosis, as well as for the prophylaxis of invasive aspergillosis and candidiasis in high-risk patients (10).
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.